Cong Wang
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Lipids, and Metabolism
- Molecular Biology top 10%
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing
Papers in ⓘ
-
- Cancer-related molecular mechanisms research 24
- MicroRNA in disease regulation 22
- Cancer, Lipids, and Metabolism 15
- Cancer, Hypoxia, and Metabolism 14
-
- RNA modifications and cancer 16
- Circular RNAs in diseases 13
- Co-authors
- Qingguang Liu (7 shared papers)Zhikui Liu (7 shared papers)Bowen Yao (7 shared papers)Qing Li (6 shared papers)Liang Wang (6 shared papers)Kangsheng Tu (5 shared papers)Yufeng Wang (5 shared papers)Meng Xu (4 shared papers)
- Journals
- OncoTargets and Therapy (4 papers)Oncotarget (4 papers)Medicine (3 papers)Frontiers in Genetics (3 papers)Biomedicine & Pharmacotherapy (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Cong Wang
101 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 122
- Cancer Research 1.1k
- Molecular Biology 1.2k
- Oncology 443
- Pulmonary and Respiratory Medicine 374
- Otorhinolaryngology 33
Countries citing papers authored by Cong Wang
This map shows the geographic impact of Cong Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cong Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cong Wang more than expected).
Fields of papers citing papers by Cong Wang
This network shows the impact of papers produced by Cong Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cong Wang. The network helps show where Cong Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Cong Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 109 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 203 | |
| 2 | 2018 | 111 | |
| 3 | 2018 | 108 | |
| 4 | 2019 | 83 | |
| 5 | 2017 | 72 | |
| 6 | 2020 | 70 | |
| 7 | 2009 | 68 | |
| 8 | 2013 | 62 | |
| 9 | 2016 | 61 | |
| 10 | 2016 | 52 | |
| 11 | 2016 | 50 | |
| 12 | 2019 | 45 | |
| 13 | 2021 | 45 | |
| 14 | 2018 | 44 | |
| 15 | 2012 | 42 | |
| 16 | Genome-wide target interactome profiling reveals a novel EEF1A1 epigenetic pathway for oncogenic lncRNA MALAT1 in breast cancer. | 2019 | 41 |
| 17 | 2018 | 40 | |
| 18 | 2008 | 39 | |
| 19 | 2018 | 39 | |
| 20 | 2017 | 38 |
About Cong Wang
Cong Wang is a scholar working on Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine, Oncology and Surgery, having authored 109 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (24 papers), MicroRNA in disease regulation (22 papers), RNA modifications and cancer (16 papers), Cancer, Lipids, and Metabolism (15 papers), Ferroptosis and cancer prognosis (15 papers), Cancer, Hypoxia, and Metabolism (14 papers), Circular RNAs in diseases (13 papers) and Lung Cancer Treatments and Mutations (9 papers). The work is most often cited by research in Cancer Research (1.1k citations), Molecular Biology (1.2k citations), Oncology (443 citations), Pulmonary and Respiratory Medicine (374 citations) and Otorhinolaryngology (33 citations). Cong Wang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Qingguang Liu, Zhikui Liu, Bowen Yao, Qing Li, Liang Wang, Kangsheng Tu, Yufeng Wang, Meng Xu, Yufeng Cheng and Liankang Sun. Their work appears in journals such as OncoTargets and Therapy, Oncotarget, Medicine, Frontiers in Genetics and Biomedicine & Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.